LNH 2402
Alternative Names: 177Lu-DOTA-RM2; LNH-2402Latest Information Update: 31 Mar 2025
At a glance
- Originator Life Molecular Imaging
- Developer Lantheus Holdings
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours